Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.260
0.00 (0.00%)
At close: Jun 12, 2026, 4:00 PM EDT
1.247
-0.013 (-1.04%)
After-hours: Jun 12, 2026, 6:38 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $43.32 million as of June 12, 2026. Its market cap has decreased by -30.69% in one year.
Market Cap
43.32M
Enterprise Value
37.96M
1-Year Change
-30.69%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $43.32M, a decrease of -79.10%. That is a compound annual growth rate of -48.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 43.32M | -5.26% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 47.80M |
| Actuate Therapeutics | 47.61M |
| Radiopharm Theranostics | 47.10M |
| Metagenomi Therapeutics | 46.87M |
| aTyr Pharma | 46.61M |
| Estrella Immunopharma | 46.48M |
| KALA BIO | 45.92M |
| Genenta Science | 45.29M |